Gujarat Inject Kerala Ltd - 524238 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Gujarat Inject reported robust FY26 financial results with revenue growing 91% YoY to Rs. 36.32 crore and net profit increasing 78% YoY to Rs. 1.81 crore. The company also secured new solar PV module orders worth Rs. 14.49 crore and is rebranding to REGENOVA RENEWTECH LIMITED, reflecting its strategic shift towards renewable energy.
May 25 2026 13:39:03
Gujarat Inject Kerala Ltd - 524238 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday, 20Th May, 2026 And Submission Of Audited Financial Results (Standalone) For The Fourth Quarter And Year Ended On 31St March, 2026
Gujarat Inject's board approved standalone financial results for Q4 & FY26. Full-year revenue surged 61.15% to ₹30.70 crore, while net profit grew 60.74% to ₹1.64 crore. Auditors M/s. S. Mandawat & Co. provided an unmodified opinion on the results.
May 20 2026 18:59:36
Gujarat Inject Kerala Ltd - 524238 - Announcement under Regulation 30 (LODR)-Change in Directorate
Gujarat Inject (Kerala) Ltd. announced the appointment of Mr. Deepak Diwan Bachwani as its new Whole Time Director and Chairman, effective May 16, 2026. This appointment follows the resignation of Mr. Murli Shivshankaran Nair from the roles of Managing Director and Chairman due to personal commitments. Mr. Bachwani brings expertise in sustainability and international trade.
May 16 2026 19:18:56
Gujarat Inject Kerala Ltd - 524238 - Announcement under Regulation 30 (LODR)-Resignation of Chairman and Managing Director
Gujarat Inject Kerala Limited's Managing Director and Chairman, Murli Shivshankaran Nair, resigned effective May 16, 2026. Deepak Diwan Bachwani, previously a Non-Executive Director, has been appointed as Whole Time Director and Chairman, ensuring continuity in leadership.
May 16 2026 19:15:35
Gujarat Inject Kerala Ltd - 524238 - Board Meeting Intimation for Board Meeting For Consideration Of Audited Financial Results For The Quarter & Year Ended 31St March, 2026.
Gujarat Inject's Board of Directors will convene on May 20, 2026, to consider and approve the audited financial results for the quarter and full financial year ended March 31, 2026. The meeting will also review the Statutory Auditors' Report.
May 15 2026 19:55:56
Read More